AmorChem

AmorChem is a Canada-based early-stage venture capital fund focused on life sciences and biotechnology investments originating from academic research. Founded in 2011 and headquartered in Montreal, the firm specializes in transforming research-stage projects into commercial biotech companies. It invests at the pre-seed and seed stages, funding translational research to bridge the gap between scientific discovery and commercialization. AmorChem works closely with universities and research institutions, supporting the creation of spinout companies around proprietary technologies. Its strategy centers on building new therapeutics and healthcare innovations through a hands-on venture creation model.